(Q43610446)

25 November 2017

title

Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone (English)

1 reference

25 November 2017

0 references

1 reference

R Ganguli

1

1 reference

25 November 2017

J S Brar

series ordinal

2

1 reference

25 November 2017

Z Ayrton

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

25 November 2017

published in

Schizophrenia Research

1 reference

25 November 2017

volume

49

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

261-267

1 reference

The distribution of body mass index among individuals with and without schizophrenia.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Weight gain associated with psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Weight reduction in schizophrenics by molindone

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Weight Changes With Schizophrenic Psychosis and Psychotropic Drug Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Clozapine-induced weight gain: prevalence and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Weight gain associated with neuroleptic medication: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

Weight gain: side effect of atypical neuroleptics?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900080-3

7 January 2021

10.1016/S0920-9964(00)00080-3

Identifiers

DOI

1 reference

25 November 2017

1 reference